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Purpose: The World Health Organization advocates that all pregnant women in areas where 
anemia is prevalent receive supplements of iron and folic acid. However, owing to a myriad 
of factors, the uptake of iron and folic acid supplementation (IFAS) is still low in many 
countries. Therefore, this study was conducted to assess the prevalence of IFAS and its 
associated factors among pregnant women.
Patients and Methods: A cross-sectional study was conducted at a hospital in Muntinlupa, 
Philippines, between March and August 2019 among 280 pregnant women. A systematic 
random sampling technique was used to select participants. Data were collected using 
interviewer-administered questionnaires. Multivariable logistic regression analyses were 
employed to identify factors associated with the prevalence of IFAS among pregnant women.
Results: Among 280 pregnant women, a majority (85.6%, n= 238) took IFAS during 
pregnancy. Among the respondents, 128 (45.9%) women had knowledge about signs and 
symptoms of anemia, 126 (45.3%) had knowledge of the benefits associated with IFAS, and 
42 (15.4%) had knowledge about side effects associated with IFAS. The main sources of 
information about IFAS were health care providers (41.8%), followed by community health 
workers (CHWs) (14.6%). Maternal knowledge concerning IFAS benefits (OR = 2.50, CI =  
1.04–5.97, p=0.04) was positively associated with the prevalence of IFAS.
Conclusion: Maternal knowledge about the benefits of taking IFAS was significantly 
associated with the prevalence of IFAS among pregnant women in Muntinlupa, 
Philippines. There is a pressing need to improve health education on the benefits of IFAS 
among pregnant women to increase its prevalence. This emphasizes the necessity of 
increased involvement of health care providers and CHWs to increase women’s knowledge 
of IFAS benefits and support them through pregnancy.
Keywords: anemia, pregnancy, health education, health care providers, community health 
workers
Introduction
The World Health Organization (WHO) estimates that worldwide, 613 million 
women at reproductive age are anemic, and a vast majority of anemic pregnant 
women reside in Asia and Africa.1 In the Philippines, anemia prevalence among 
pregnant women remains high as shown in the National Nutrition Surveys in 2003 
(43.9%), 2008 (42.5%), and 2013 (25.2%).2,3 Anemia during pregnancy (ie 
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hemoglobin level less than 11 g/dL) can lead to adverse 
maternal and perinatal outcomes, including mortality.4–13 
The WHO recommends that all pregnant women in areas 
where anemia is prevalent should receive iron and folic 
acid supplementation (IFAS).1,14 Despite the WHO recom-
mendations, the utilization of IFAS is still low in many 
countries, especially those with low economic 
resources.11,15
The Philippines’ national guideline for the prevention 
of micronutrient deficiencies highlights the need for daily 
IFAS during pregnancy.16 Various factors such as socio- 
demographic and health factors determine the IFAS regime 
for pregnant women in some areas including the 
Philippines. These factors include forgetfulness, travel, 
age, literacy, socioeconomic status, cost of iron and folic 
acid tablets, perceived side effects, supplement stock-outs, 
birth order, difficult accessing and poor utilization of 
antenatal health care services, and comprehensive knowl-
edge of anemia as well as quality of counselling on IFAS 
during pregnancy.17–34 Nevertheless, supplementation is 
the most widely employed strategy to alleviate iron defi-
ciency, both globally and locally.3,35 Women take IFAS 
during pregnancy to prevent specific micronutrient defi-
ciencies under the programs provided by the government 
of the Philippines.3,35,36 In the Philippines, Patient-level 
care is provided at widely utilized barangay (village) 
health stations (BHS) that are operated by trained mid-
wives. The midwife in each BHS identified all the preg-
nant women who had received IFAS from that BHS during 
their pregnancy.37 At each monthly prenatal visit to the 
BHS, IFAS is provided free of charge to pregnant 
women.35,38 The Philippines National Survey in 2008, 
which measured the uptake of IFAS, found consumption 
of 82.4% of prescribed pills among pregnant women.39,40 
Thus, taking iron and folic acid supplements is an impor-
tant strategy to prevent anemia among pregnant women. 
The present research is one of the studies that seek to 
check the effectiveness of the current Philippines program 
with the strategy whereby women would receive free IFAS 
from the BHS during pregnancy.
However, no published data exist to assess the admin-
istration of such supplementation and its associated factors 
among pregnant women in the Philippines. The 
Muntinlupa City of the Philippines is located in the 
Luzon region and divided into nine districts, and the city 
has a public city hospital—the Muntinlupa City hospital. 
The hospital provides health services at the lowest possible 
costs; therefore, in Muntinlupa, not only rich but also poor 
pregnant women use public hospitals. Although it is often 
difficult to approach poor pregnant women in studies, this 
study was able to approach pregnant women across all 
economic levels by conducting the study at the hospital. 
Thus, this study was conducted specifically to assess the 
prevalence of IFAS among pregnant women and its asso-
ciated factors in Muntinlupa, Philippines.
Patients and Methods
Study Site and Design
A cross-sectional study was conducted at the women’s 
health center in the hospital of Muntinlupa City and data 
were collected between March and August 2019. In addi-
tion, 900 pregnant women were receiving antenatal care 
during the data collection period based on a search of 
electronic records. Muntinlupa City has nine districts, 
each with one or two government health centers, including 
an outpatient clinic. The Muntinlupa City hospital pro-
vides health services at the lowest possible costs. In addi-
tion, the women’s health center in the hospital provides 
counseling to all women living in the area.
Sample Size Determination and Sampling 
Procedure
The required sample size for this study was determined 
using the single population proportion estimation formula 
and considering the following assumptions: the rate of 
taking IFAS among pregnant women was 82.4% in 2008 
in the Phillippines,39 a 95% confidence interval, and 5% 
acceptable margin of error. The calculated sample size 
required 267 participants. Finally, considering a 10% non- 
response rate, the final sample size was set at 280. After 
the proportional allocation of pregnant women in the 
women’s health center, a systematic random sampling 
technique was employed to include 280 participants. 
Sampling fraction (K) was N/n = 900/280 = 3.2. 
Thereafter, the lottery method was employed to identify 
the first pregnant woman for an interview and upon selec-
tion, every third pregnant woman thereafter was chosen to 
commence the interview. Consequently, all women were 
identified.
Study Population and Sampling
The study population consists of pregnant women, aged 
18–45 years, attending antenatal check-ups in the respec-
tive hospital and living in Muntinlupa City. Each partici-
pant provided written, informed consent. Women who 
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were seriously ill at the time of data collection were 
excluded. The interview was conducted just after receiving 
the antenatal care service.
Data Collection Methods
Data were collected using the interviewer-administered 
questionnaire. A structured, interviewer-administered 
questionnaire consisting of 26 closed-ended questions 
were developed, pretested, and used in this study. 
Questions were categorized into: socio-demographic char-
acteristics (6), maternal knowledge on taking IFAS and 
knowledge on major signs and symptoms of anemia (19), 
and current practices towards IFAS (1). To ensure the 
reliability of the questionnaire, we adopted a test-retest 
method where a repeat pre-test was conducted after two 
weeks, while Cohen’s kappa statistic was used to measure 
the level of agreement between the results from the pre- 
tests. Since all the questions had a kappa value of above 
0.7 after the comparison, the questionnaire was considered 
reliable, thus, all the questions were retained. To ensure 
validity, the tool was shared and discussed with experts 
from the division of nutrition of the City Government 
Office, as well as the study supervisors. The obtained 
feedback was used to refine the tool. The questionnaires, 
which were written in Tagalog (ie the national language of 
the Philippines), were administered by trained research 
assistants to all pregnant women who met the inclusion 
criteria and consented to the study.
Data Analyses
Descriptive statistics were employed to describe the study 
population in relation to socio-demographic and other 
relevant variables and to display findings through means, 
percentages, and 95% confidence intervals. The primary 
outcome variable for this study was the prevalence of 
IFAS, which was assessed with the question: “Have you 
taken IFAS during the current pregnancy?” To assess the 
level of knowledge about IFAS during pregnancy, respon-
dents were asked three questions including (1) major signs 
and symptoms of anemia during pregnancy, (2) the bene-
fits of taking IFAS, and (3) side-effects of taking IFAS. 
The respondents’ level of knowledge was computed by 
summing up seven items with respect to the signs and 
symptoms of anemia (“Feels weak,” “Looks pale,” 
“Palpitations,” “Headaches,” “Dizziness,” “Tiredness and 
easily fatigued,” and “Swollen legs”), five items concern-
ing the benefits of IFAS (“Prevents anemia among preg-
nant women,” “Protects mother from sicknesses,” “Gives 
mother strength during delivery,” “Increases the amount of 
blood,” and “Facilitates the fetus to grow healthy and 
strong”), and seven items regarding the side-effects of 
IFAS (“Epigastric pain,” “Abdominal pain,” “Nausea,” 
“Vomiting,” “Diarrhea,” “Constipation,” and “Feces may 
turn black”). A correct answer for each item was scored as 
“1” and the incorrect answer was scored as “0.” Pregnant 
women were classified as highly knowledgeable and 
slightly knowledgeable about the benefits and side effects 
of taking IFAS and major signs and symptoms of anemia 
during pregnancy. Those who scored greater than or equal 
to the mean value were considered as highly knowledge-
able and those who scored less than the mean value were 
considered as slightly knowledgeable. The distribution of 
the knowledge scores was approximately normal; there-
fore, the average value was used for the analysis. To test 
for multicollinearity among independent variables, we ran 
collinearity diagnostics to calculate the variance inflation 
factor and tolerance for each variable. Bivariate logistic 
regression analyses were carried out to evaluate the unad-
justed associations between dependent variables and each 
of the independent variables. Significant variables in the 
bivariate logistic regression analyses (p-value < 0.01) were 
incorporated into the multivariable logistic regression ana-
lyses to identify factors associated with the prevalence of 
IFAS among pregnant women.
In this study, pregnant women who did not answer 
questions about their age, gestation, and whether they 
took IFAS were excluded from the analysis. Data were 
analyzed using the Statistical Package for the Social 
Sciences (SPSS) 26.0 (IBM Corp., Armonk, NY, USA).
Ethical Considerations
The study was conducted by following per under the 
declaration of Helsinki. The study was approved by the 
Hospital of Muntinlupa, Research Operation Office (No. 
2019–02), and Kobe City College of Nursing, Ethics, 
and Research Committee (No. 18112–05). Participation 
in the study was purely voluntary. The study participants 
provided verbal and written informed consent before the 
commencement of the interview. Participants were told 
they could withdraw from the study anytime without 
any consequences. The purpose of the study and the 
assurance of confidentiality of information were 
explained to participants. They were also told they 
could decide not to answer any question they felt 
uncomfortable with.
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Results
A total of 280 pregnant women participated in the study. 
The mean age of the study participants was 28.3 (SD ± 
6.5) years, with a majority (51.1%, n=143) between 25 and 
34 years of age. Regarding their occupational status, 
35.6% (n=98) were employed. Relating to the highest 
level of education attained by the respondents, a majority 
(88.2%, n=246) had a secondary school degree or above. 
The highest proportion of respondents (59.6%, n=159) 
earned an average household monthly income below 
9999 Philippines pesos. The poverty threshold of the 
Philippines in 2018 was 10,000 Philippines pesos.41 
More than half of the women were multipara (59.3%, 
n=166). Furthermore, the mean gestational age of pregnant 
women was 29.9 (SD = ±8.7) weeks, and the majority of 
the participants were in their third trimester (78.2%, 
n=219) (Table 1).
Among the respondents, the majority (85.6%, n=238) 
were taking IFAS during their current pregnancy. Those 
found knowledgeable in the assessment of various aspects 
of IFAS were categorized as follows: knowledge on signs 
and symptoms of anemia: 45.9% (n=128), benefits of tak-
ing IFAS: 45.3% (n=126), and side effects of IFAS: 15.4% 
(n=42) (Table 1). The highest proportion of knowledge 
related to the various benefits of IFAS among pregnant 
women was for “Prevents anemia among pregnant 
women” (76.4%), followed by “Increases the amount of 
blood” (50.7%), “Facilitates the fetus to grow healthy and 
strong” (46.1%), “Protects mother from sicknesses” 
(43.9%), and “Gives mothers strength during delivery” 
(41.1%) (Figure 1).
Pregnant women reported various sources of IFAS 
information. The main source of information was 
health care providers (41.8%). Other sources of infor-
mation included community health workers (CHWs) 
(14.6%), relatives/friends/neighbors (8.6%), the 
Internet (6.8%), posters/television/radio (5.4%), news-
papers/magazines/books (1.4%), and community lea-
ders (0.4%) (Figure 2).
In the logistic regression analysis (Table 2), maternal 
knowledge on benefits of taking IFAS was significantly 
associated with iron-folic acid consumption (OR=2.50, 
1.04–5.97, P=0.04).
Discussion
This study sought to assess the prevalence of IFAS 
among pregnant women and its associated factors. The 
main findings of the study were: (1) The majority of the 
women took IFAS during pregnancy; (2) less than half 
of the respondents had a high level of IFAS knowledge; 
(3) the main source of IFAS information was health care 
providers; (4) maternal knowledge on benefits of taking 
IFAS was the main factor significantly associated with 
prevalence of IFAS.
Notably, the prevalence rate of IFAS in this study 
(85.6%) was almost the same as the rate of the 
Philippines National Survey (82.4%) in 2008.39 Similar 
findings on the prevalence of IFAS have also been 
reported in neighboring countries, such as Cambodia42 
and Nepal.43 This study found that pregnant women 
who were highly knowledgeable regarding the benefits 
of taking IFAS were more likely to continue taking 
IFAS than those who were slightly knowledgeable. 
These findings are consistent with reports on IFAS from 
similar rural settings in low and medium-income coun-
tries (LMIC), such as Indonesia,44 Ethiopia,23,45 and other 
countries (ie Afghanistan, Kenya, Nigeria, and 
Senegal).46 Thus, successful uptake of IFAS is linked to 
knowledge pertaining to the benefits of taking IFAS dur-
ing pregnancy. Findings from this study show that such 
knowledge during pregnancy has a significant effect on 
the prevalence of IFAS. Knowledge about IFAS is 
a crucial channel for taking iron and folic acid during 
pregnancy. Therefore, the observed relationship between 
the level of knowledge concerning IFAS and the preva-
lence of IFAS is as expected. This finding is consistent 
with studies conducted in other areas of the Philippines 
and other countries.21,26,35,47–49
From this study, it was found that less than half of 
the women did not know that IFAS benefits include 
strengthening mothers during delivery and facilitates 
the fetus to grow healthy and strong. Few studies dis-
cussed the detailed content of the educational messages 
used to describe the benefits of taking IFAS. Most 
research conclude that women need to be motivated to 
take IFAS but focus on “benefit” messages such as 
“stronger” mothers, “healthier” babies, and reinforcing 
the belief that iron “increases the production of 
blood.”50 Further, this study showed that many pregnant 
women did not know about the side effects of taking 
IFAS. It has been reported that side effects and manage-
ment of taking IFAS are important for improving pre-
valence of IFAS.23 Education about taking IFAS through 
antenatal care services is effective, but education 
focused on strengthening the benefit message as well 
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as the side effects and its management are also 
expected. Moreover, these findings necessitate counsel-
ing on specific IFAS aspects concerning pregnant 
women and are supported by studies conducted in 
Ethiopia,51,52 Iran,53 and Pakistan.54
When aggregated by source, the majority of women in 
this study reported their source of information was the 
health care provider. This was followed by CHWs, 
friends/neighbors, the Internet, poster/television/radio, 
books, and finally community leaders. Health care provi-
ders could play a major role in advocating counseling for 
IFAS to increase knowledge about IFAS among pregnant 
women; about one-third of health care providers were 
CHWs. Interestingly, friends, the Internet, and television/ 
radio was not the main source of information. Possible 
explanations for this finding may include that (a) CHWs 
are closer to the community resulting in better interperso-
nal communication and hence better explanations to 
women about IFAS;55 (b) information that passes through 
friends, the Internet, and television/radio is not usually 
prepared by professionals who know how to effectively 
reach the community with messages. In the Philippines, 
CHWs are known as Barangay Health Workers (BHW). 
Our previous publication reported that the BHWs play 
a potentially important role in supporting women during 
pregnancy and postpartum through home-visit services in 
the community56 Therefore, increasing refresher training 
on IFAS among CHWs to enhance their IFAS knowledge 
is important as they are a common source of IFAS infor-
mation as in addition to health care providers.
It has been also reported that pregnant women’s husbands 
or family members contribute to the success of managing 
anemia in pregnancy.57 Therefore, it is important for health 
care providers to educate not only pregnant women but also 
their husbands and family members. There is a need to 
constantly provide pregnant women and their family mem-
bers with information, education, and communication mate-
rials on IFAS, which they can always refer to and refresh 
their knowledge. Additionally, it might be necessary to pro-
vide a counseling program that improves the knowledge of 
not only pregnant women but also their husbands and 
families by utilizing CHWs.
Limitations
This study has some limitations. First, a few of the women 
in the first trimester might not have had taken IFAS yet 
because they had not received their first antenatal care 
session for receiving IFAS in BHS. Second, the small 
sample size limited the logistic regression analysis. Third, 
the study samples were selected from a hospital-based set-
ting, and the level of knowledge could be different from 
a community-based setting. Fourth, the level of knowledge 
regarding IFAS among pregnant women was determined 
Table 1 Socio-Demographic Characteristics, Prevalence of IFAS, 
and Maternal Knowledge of Pregnant Women (n=280)
Variable Number Percent
Age in years
Under 25 85 30.4
25–34 143 51.1






Secondary incomplete 28 10.0
Above secondary 246 88.2
Income (month)
Under 9999 pesos 159 59.6





First trimester 19 6.8
Second trimester 42 15.0
Third trimester 219 78.2
Taking IFAS during the current pregnancy
Not taking IFAS 40 14.4
Taking IFAS 238 85.6
Mother’s knowledge on signs and symptoms of anemia
Slightly knowledgeable 151 54.1
Highly knowledgeable 128 45.9
Mother’s knowledge on benefits of taking IFAS
Slightly knowledgeable 152 54.7
Highly knowledgeable 126 45.3
Mother’s knowledge on side-effects of IFAS
Slightly knowledgeable 230 84.6
Highly knowledgeable 42 15.4
Abbreviation: IFAS, iron and folic acid supplementation.
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using a self-report survey, which is prone to bias and might 
affect the estimation of the actual level of knowledge of the 
target population. Finally, the types of factors considered to 
be associated with IFAS were limited.
Conclusion
Maternal knowledge about the benefits of taking IFAS 
was significantly associated with the prevalence of 
IFAS among pregnant women. The main source of 
IFAS information was health care providers and 
CHWs. Thus, there is a pressing need to improve 
health education on the benefits of IFAS among preg-
nant women to increase its prevalence. This under-
scores the knowledge level needed to support women 





































































Figure 2 Sources of iron and folic acid supplementation information.
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Table 2 Multivariate Regression Analyses of IFAS Prevalence Status Among Pregnant Women
Variables Took Iron-Folic 
Acid
Did Not Take Iron-Folic 
Acid
Univariate Analysis Multivariate Analysis
n Percent n Percent OR 95% CI P OR 95% CI P
Age in years
Under 25 70 82.4% 15 17.6% 1.00 1.00
25–34 124 87.9% 17 12.1% 1.56 0.74–3.32 0.25 1.66 0.69–3.99 0.26
35 and above 44 84.6% 8 15.4% 1.18 0.46–3.01 0.73 1.17 0.39–3.54 0.78
Occupation
Unemployed 147 83.5% 29 16.5% 1.00 1.00
Employed 87 89.7% 10 10.3% 1.72 0.8–3.69 0.17 1.47 0.63–3.42 0.37
Income (month)
Under 9999 pesos 130 82.3% 28 17.7% 1.00 1.00
Over 10,000 pesos 97 90.7% 10 9.3% 2.09 0.97–4.51 0.06 1.71 0.76–3.86 0.19
Gravidity
Primipara 100 83.1% 12 16.9% 1.00 1.00
Multipara 138 89.3% 28 10.7% 0.59 0.29–1.22 0.15 0.63 0.27–1.45 0.28
Mother’s knowledge on signs and symptoms of anemia
Slightly knowledgeable 131 86.8% 20 13.2% 1.00 1.00
Highly knowledgeable 106 84.1% 20 15.9% 0.81 0.41–1.58 0.54 0.51 0.22–1.15 0.10
Mother’s knowledge on benefits of taking IFAS
Slightly knowledgeable 123 80.9% 29 19.1% 1.00 1.00
Highly knowledgeable 114 91.9% 10 8.1% 2.69 1.25–5.76 0.01* 2.50 1.04–5.97 0.04*
Mother’s knowledge on side-effects of IFAS
Slightly knowledgeable 192 83.8% 37 16.2% 1.00 1.00
Highly knowledgeable 38 92.7% 3 7.3% 2.44 0.72–8.33 0.12 2.71 0.73–10.13 0.14
Notes: Significant association at 95% CI, *significant at P < 0.05. 
Abbreviations: IFAS, iron and folic acid supplementation; CI, confidence interval; OR, odds ratio.
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